BETRF.US BetterLife Pharma Inc

Healthcare Biotechnology USA Stocks
0.1410 USD
Close of Nov 14, 2026
0.0280 0.3310
Market cap
USD 91.8M
P/E
-
P/B
13.65x
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jul 2026.

Is BETRF.US undervalued?

Graham number

The Graham number of BetterLife Pharma Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

BetterLife Pharma Inc fundamental analysis

No fundamental analysis for BetterLife Pharma Inc yet.

BetterLife Pharma Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About BetterLife Pharma Inc

BetterLife Pharma Inc., a biotechnology company, engages in the development of psychedelic-derived compounds. It focuses on developing and commercializing BETR-001, a non-hallucinogenic and non-controlled LSD derivative to treat neuro-psychiatric and neurological disorders. Its products also comprise MM-001, a topical cream for local intravaginal use to treat HPV-induced cervical intraepithelial neoplasia; and MM-003, a patent pending proprietary interferon alpha-2b inhalati…

Full company profile